Gresham Gwendolyn 4
4 · Core Laboratories Inc. /DE/ · Filed Jan 5, 2026
Insider Transaction Report
Form 4
Transactions
- Tax Payment
Common Stock
2025-12-31$16.03/sh−19,301$309,395→ 33,226 total - Exercise/Conversion
Common Stock
2025-12-31+24,952→ 52,527 total - Exercise/Conversion
Performance Shares
2025-12-31−24,952→ 0 totalExercise: $0.00→ Common Stock (24,952 underlying)
Footnotes (1)
- [F1]These shares were awarded as restricted performance shares in February 2023, as disclosed in the Reporting Person's Form 4 filing on February 21, 2023. The Company finished in the 68th percentile of return on invested capital among the Bloomberg Peer Group at the conclusion of the performance period on December 31, 2025. Therefore, the performance criteria and requirements for vesting have been satisfied at 116.5% of the target award level, and such number of shares vested on December 31, 2025.